ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1686 • 2018 ACR/ARHP Annual Meeting

    Rule-Based Algorithm Using Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria to Identify Patients with Systemic Lupus Erythematosus (SLE) from Electronic Health Record (EHR) Data

    Anika S. Ghosh1, Theresa L. Walunas2, Kathryn L. Jackson1, Ahn H. Chun3, Daniel L. Erickson3, Karen Mancera-Cuevas4, Abel N. Kho3 and Rosalind Ramsey-Goldman5, 1Center for Health Information Partnerships, Northwestern University, Chicago, IL, 2Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4Rheumatology, Northwestern University, Chicago, IL, 5FSM, Northwestern University, Chicago, IL

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and…
  • Abstract Number: 1687 • 2018 ACR/ARHP Annual Meeting

    Systemic Lupus Flares Based on BILAG and Sledai Rules Are Inconsistent, but May be Better Understood Using Visual Analogue Scales

    Aikaterini Thanou1, Anca Askanase2, Cristina Arriens3, Teresa Aberle3, Stan Kamp3, Eliza Chakravarty3, Judith A. James4 and Joan T. Merrill3, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Columbia University, College of Physicians & Surgeons, New York, NY, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Evaluation of lupus flares is inconsistent using glossary-based definitions for grading (1). BILAG 2004 rates flares by new/worse organ scores. The SELENA-SLEDAI flare index…
  • Abstract Number: 1688 • 2018 ACR/ARHP Annual Meeting

    Changes in Heart Rate Variability Reflect Clinical Improvement and Flare in Systemic Lupus Erythematosus

    Aikaterini Thanou1, Stavros Stavrakis2, Stan Kamp3, Paul Kamp3, Teresa Aberle3, Cristina Arriens3, Eliza Chakravarty3, Judith A. James4 and Joan T. Merrill3, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Ok, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Decreased heart rate variability (HRV) reflects autonomic dysfunction and inflammatory dysregulation and has been observed in SLE. We examined associations of HRV with clinical…
  • Abstract Number: 1689 • 2018 ACR/ARHP Annual Meeting

    Explaining the Discrepancy between Physician and Patient-Reported Measures of Disease Activity in Systemic Lupus Erythematosus

    Nathaniel J. Harris1, Amanda M. Eudy2 and Megan E. B. Clowse2, 1Department of Medicine, Duke University, Durham, NC, 2Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC

    Explaining the Discrepancy between Physician and Patient-Reported Measures of Disease Activity in Systemic Lupus Erythematosus Background/Purpose: Patient-reported measures of disease activity provide useful adjuncts to…
  • Abstract Number: 1690 • 2018 ACR/ARHP Annual Meeting

    Increased Sensitivity Οf Τhe New (2017) Αnd Τhe 2012 SLICC As Compared Τo Τhe Acr 1997 Classification Criteria Ιn Early Systemic Lupus Erythematosus (SLE): The 2017 Αnd 2012 Criteria May Classify Non-Overlapping Subgroups Οf Patients

    Christina Adamichou1, Dionysios Nikolopoulos2, Alessandra Bortoluzzi3, Emmanouil Papastefanakis1, Antonis Fanouriakis2, Eleni Kalogiannaki1, Irini Gergianaki1, Prodromos Sidiropoulos1 and George Bertsias1, 1Department of Rheumatology, Clinical Immunology and Allergy, University of Crete, School of Medicine, Heraklion, Greece, 24th Department of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece, 3Section of Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-University Hospital S. Anna, Cona Ferrara, Italy

    Background/Purpose: SLE diagnosis can be challenging especially at the early stages, and existing classification criteria are biased towards classifying patients with long-standing disease. A joined…
  • Abstract Number: 1691 • 2018 ACR/ARHP Annual Meeting

    Application of the Doris Algorithm for the Definition of Disease Remission and Its Relation with Damage Accrual over a 2-Year Period in a Cohort of Italian Patients with Systemic Lupus Erythematosus Classified According to Clinical Disease Patterns

    Francesca Dall'Ara1, Laura Andreoli2, Federica Migliorati3, Giuseppe Armentaro3, Micaela Fredi4, Micol Frassi5, Mara Taraborelli3, Franco Franceschini4, Stefano Calza6 and Angela Tincani3, 1Department of Clinical and Experimental Sciences,Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, Brescia, Italy, 2Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 3Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, BRESCIA, Italy, 4Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, Brescia, Italy, 5Spedali Civili of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, BRESCIA, Italy, 6Unit of Biostatistics and Biomathematics & Unit of Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is characterized by a fluctuating course. To achieve sustained remission is the ultimate goal of maintenance treatment. However the definition…
  • Abstract Number: 1692 • 2018 ACR/ARHP Annual Meeting

    Using ICD-10-CM Codes to Identify Patients with Systemic Lupus Erythematosus in the Electronic Health Record

    April Barnado1, Robert Carroll2, Joshua C. Denny2 and Leslie Crofford1, 1Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 2Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: The electronic health record (EHR) serves as a powerful tool to enable researchers to collect a large cohort of patients across the healthcare system. …
  • Abstract Number: 1693 • 2018 ACR/ARHP Annual Meeting

    Innate, Adaptive, and TNF-Superfamily Immune Pathways Inform a Lupus Disease Activity Immune Index That Characterizes Disease Activity in SLE

    Melissa E. Munroe1,2, Joel M. Guthridge1, Rufei Lu1,3, Joseph M. Kheir1, Bolanle Adebayo1, Susan R. Macwana1, Hua Chen1, Virginia C. Roberts1, Mohan Purushothaman2, Sanjiv Sharma2, Teresa Aberle1, Stan Kamp1, Cristina Arriens1, Eliza Chakravarty1, Katherine Thanou1, Joan T. Merrill1 and Judith A. James4,5, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Progentec Diagnostics, Inc., Oklahoma City, OK, 3Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease marked by immune dysregulation. A comprehensive but cost-effective tool to track relevant mediators of altered…
  • Abstract Number: 1694 • 2018 ACR/ARHP Annual Meeting

    The Lupus Severity Index Accurately Identifies Patients with Severe SLE in a Multi-Ethnic Cohort

    Christine A. Peschken1, Carol Hitchon2, David Robinson3, Ada Man3, Annaliese Tisseverasinghe3 and Hani El-Gabalawy2, 1RR 149G, University of Manitoba, Winnipeg, MB, Canada, 2University of Manitoba, Winnipeg, MB, Canada, 3Rheumatology, University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: The Lupus Severity Index (LSI)* was recently proposed to stratify patients by disease severity for clinical research. The LSI ranges from 0-10, is calculated…
  • Abstract Number: 1695 • 2018 ACR/ARHP Annual Meeting

    Differences between Early and Adult-Onset Systemic Lupus Erythematosus in Cohort of Argentinian Patients

    Rodrigo Aguila Maldonado1, Dora Pereira2, Gisela Pendon3, Alberto Spindler4, Cecilia N. Pisoni5, Julio Hofman6, María Victoria Collado7, Judith Sarano8, Cesar Graf9, Graciela N Gómez10, Paula Alba11, Claudia Elizabeth Pena1, Ana Carolina Costi12, Adrian Salas13, Ana Curti14, Oscar Rillo15, Silvia Beatriz Papasidero16, Veronica Bellomio17, Susana Roverano18, Marcela Schmid19, Alberto Allievi20, Sebastián Muñoz20, Walter J. Spindler21, Andrea Gonzalez22, Ana María Beron23, Rosana Quintana24, Agustina Damico25, Andrea Gómez26, Sergio Tolosa27, Enrique Soriano28, Alicia Eimon29, Marta Silvia Espósito6, Leila Romina Ferreyra Mufarregue30, Juan Pablo Ruffino30, Verónica Saurit31, Edson Hernán Chiganer30, Fabian Risueño32, Flavia Caputo33, Edson Velozo34, Juan Soldano35, Monica Diaz36 and Mercedes Garcia1, 1Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 2Rheumatology Section, Hospital Dr. Ricardo Gutiérrez, Argentina, Buenos Aires, Argentina, 3H Gutiérrez de La Plata, La Plata, Argentina, 4Centro Médico Privado de Reumatología, Centro Médico Privado de Reumatología, Argentina, 5Internal Medicine, CEMIC, Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina, 6Consultorio Privado, Buenos Aires, Argentina, 7Rheumatology, Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, 8Instituto Lanari, Buenos Aires, Argentina, 9Centro Médico Mitre, Paraná, Argentina, 10Diaz Colodrero 2537 8° A, Instituto de Investigaciones Medicas Alfredo Lanari, Capital Federal, Argentina, 11Universidad Nacional de Cordoba, Rheumatology Unit Cordoba and Materno Neonatal Hospital, Córdoba, Argentina, 12Rheumatology Section, HIGA General San Martin La Plata, La Plata, Argentina, 13Rheumatology, HIGA General San Martin, La Plata, Argentina, 14Htal Lagomaggiori, Mendoza, Argentina, 15Hospital General de Agudos Dr Ignacio Pirovano, Argentina, Buenos Aires, Argentina, 16Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Argentina, Buenos Aires, Argentina, 17Hospital Padilla, San Miguel de Tucumán, Argentina, 18Hospital José Maria Cullen, Santa Fe, Argentina, 19Hospital Jose María Cullen, Santa Fe, Argentina, 20SAR, Buenos Aires, Argentina, 21Centro Médico Privado de Reumatología, Tucuman, Argentina, 22Hospital Eva Perón, San Martín, Argentina, 23Hospital de Clínicas, Buenos Aires, Argentina, 24Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Rosario, Argentina, 25Hospital Británico, Buenos Aires, Argentina, 26Hospital Británico de Buenos Aires, CABA, Argentina, 27Hospital San Juan Bautista, San Fernando del Valle de Catamarca, Argentina, 28Hospital Italiano, Buenos Aires, Argentina, 29CEMIC, Buenos Aires, Argentina, 30Hospital Durand, Buenos Aires, Argentina, 31Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, 32Itemédica, Bahia Blanca, Argentina, 33Hospital Posadas, Buenos Aires, Argentina, 34Sanatorio Adventista del Plata, Entre Ríos, Ecuador, 35Hospital Provincial, Rosario, Argentina, 36SAR, Bariloche, Argentina

    Background/Purpose: Approximately 20% of patients with Systemic Lupus Erythematosus (SLE) begin their illness in childhood or adolescence. These patients are described with a phenotype of…
  • Abstract Number: 1696 • 2018 ACR/ARHP Annual Meeting

    Impact of Hurricane Maria on a Cohort of Systemic Lupus Erythematosus Patients from Puerto Rico

    Luis M. Vilá1, Yaritza Berríos-López1, Carla Santiago-Burgos1, Lorena González-Sepúlveda2, Ileana Vázquez-Otero1 and Elizabeth Brown3, 1Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, 2Puerto Rico Clinical and Translational Research Consortium, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, 3Department of Pathology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: On September 20, 2017, Puerto Rico was devastated by Hurricane Maria causing severe damage to the Island infrastructure and essential services such as electricity,…
  • Abstract Number: 1697 • 2018 ACR/ARHP Annual Meeting

    Refractory Lupus Patients: How Frequent Do We See Them in the 21st Century?

    Valeria Scaglioni1, Marina Scolnik1, Enrique R Soriano1 and Guillermo J. Pons-Estel2, 1Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, 2Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario. Argentina, Rosario, Argentina

    Background/Purpose: management of systemic lupus erythematosus (SLE) patients is challenging because of the heterogeneity of the disease. While treatment of renal nephritis is more standardized,…
  • Abstract Number: 1698 • 2018 ACR/ARHP Annual Meeting

    The Association between Periodontitis and the Disease Activity of Systemic Lupus Erythematosus: A Cross-Sectional Study

    Nobuyuki Yajima1,2,3, Tsukasa Kamitani3, Mayu Saito1, Shingo Fukuma4, Yoko Koide5, Yoshimasa Okamatsu6, Kazuyuki Araki7, Yukiko Matsuda8 and Shunichi Fukuhara3, 1Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan, 2Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan, 3Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan, 4Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan, 5Department of Periodontology, Showa University School of Dentistry, Tokyo, Japan, 6Department of Special Needs Dentistry, Division of Community Based Comprehensive Dentistry, Showa University School of Dentistry, Tokyo, Japan, 7Division of Radiology, Department of Oral Diagnostic Sciences,, Showa University School of Dentistry, Tokyo, Japan, 8Division of Radiology, Department of Oral Diagnostic Sciences, Showa University School of Dentistry, Tokyo, Japan

    Background/Purpose: Periodontitis is common disease. Recently, it is pointed out that periodontitis was associated with systemic disease. There were a few studies of assessing the…
  • Abstract Number: 1699 • 2018 ACR/ARHP Annual Meeting

    Autoantibodies to M-Phase Phosphoprotein I (MPP-1: KIF20B) in Systemic Lupus Erythematosus

    May Choi1, Eric Campbell2, Ann E. Clarke1, Michelle Jung2, Claire Barber3, Yvan St.Pierre4 and Marvin J. Fritzler1, 1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 3Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 4McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: M-phase phosphoprotein (MPP-1), also termed kinesin interacting protein (KIF20B), is a 210 kDa protein that is highly expressed during cell division. Autoantibodies to MPP-1…
  • Abstract Number: 1700 • 2018 ACR/ARHP Annual Meeting

    Remission and Low Disease Activity State Prevent Hospitalizations and Emergency Room Visits in Systemic Lupus Erythematosus Patients

    Cristina Reategui-Sokolova1, Rocío Gamboa-Cárdenas1, Mariela Medina-Chinchon1, Francisco Zevallos1, Claudia Elera-Fitzcarrald1,2, Victor R. Pimentel-Quiroz1, Mariano Cucho-Venegas1, Zoila Rodriguez-Bellido1, Cesar A. Pastor-Asurza1,3, Risto Perich-Campos1, Graciela S. Alarcón4,5 and Manuel Ugarte-Gil6,7, 1Rheumatology, Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, 2Universidad Científica del Sur, Lima, Peru, 3Universidad Nacional Mayor de San Marcos, Lima, Peru, 4Universidad Peruana Cayetano Heredia, Lima, Peru, 5Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Rheumatology, Universidad Científica del Sur, Lima, Peru, 7Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru

    Background/Purpose: Although the survival rate of patients with Systemic Lupus Erythematosus (SLE) has improved over the years, patients are frequently hospitalized or evaluated in the…
  • « Previous Page
  • 1
  • …
  • 1115
  • 1116
  • 1117
  • 1118
  • 1119
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology